メタゲノムシーケンシングの世界市場予測（～2024年）...市場調査レポートについてご紹介

1 Introduction (Page No. – 15)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency Used for the Study
1.5 Market Stakeholders
2 Research Methodology (Page No. – 18)
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Breakdown of Primaries
2.1.2.2 Key Data From Primary Sources
2.2 Market Size Estimation
2.2.1 Product-Based Market Estimation
2.2.2 Application-Based Market Size Estimation
2.3 Market Breakdown and Data Triangulation
2.4 Assumptions for the Study
3 Executive Summary (Page No. – 27)
4 Premium Insights (Page No. – 31)
4.1 Metagenomic Sequencing: Market Overview
4.2 Metagenomic Sequencing Market Share, By Product & Service (2019 vs. 2024)
4.3 Market Share, By Workflow (2019 vs. 2024)
4.4 Market Share, By Technology (2019 vs. 2024)
4.5 Market, By Application, (2019 vs. 2024)
4.6 Market, By Region (2019–2024)
5 Market Overview (Page No. – 35)
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Significant Applications of Metagenomics in Various Fields
5.2.1.2 Initiatives and Funding From Government & Private Bodies for Large-Scale Sequencing Projects
5.2.1.3 Declining Cost of Sequencing
5.2.2 Restraints
5.2.2.1 End-User Budget Constraints in Developing Countries
5.2.3 Opportunities
5.2.3.1 Availability of Cloud Computing for Data Management
5.2.4 Challenges
5.2.4.1 Storage of Sequencing Data
5.2.4.2 Dearth of Skilled Professionals
6 Metagenomic Sequencing Market, By Product & Service (Page No. – 39)
6.1 Introduction
6.2 Reagents & Consumables
6.2.1 Rising Adoption of Metagenomic Sequencing is Driving the Use of Reagents and Consumables
6.3 Instruments
6.3.1 Launch of Advanced Ngs Platforms Will Support the Growth of This Segment
6.4 Services
6.4.1 Time and Cost-Effectiveness of Outsourcing Ngs Projects has Driven Demand for Services
6.5 Analysis and Data Interpretation Solutions
6.5.1 Limited Technical Knowledge of Advanced Analysis Solutions Among End Users to Hamper Market Growth
7 Metagenomic Sequencing Market, By Workflow (Page No. – 45)
7.1 Introduction
7.2 Sample Processing & Library Preparation
7.2.1 Sample Processing & Library Preparation Holds the Largest Share of the Market, By Workflow
7.3 Sequencing
7.3.1 Sanger Sequencing has Been Supplanted By Ngs Due to Its Advantages and Rapidity
7.4 Data Processing & Analysis
7.4.1 Need for Skilled Personnel to Operate Data Processing and Analytics Tools has Slowed Market Growth
8 Metagenomic Sequencing Market, By Technology (Page No. – 49)
8.1 Introduction
8.2 16s Rrna Sequencing
8.2.1 16s Rrna Sequencing is A Cost-Effective Technique for the Identification of Bacterial Strains
8.3 Shotgun Metagenomic Sequencing
8.3.1 Shotgun Metagenomic Sequencing Segment to Witness the Highest Growth Rate During the Forecast Period
8.4 Whole-Genome Sequencing and De Novo Assembly
8.4.1 Wgs Can Sequence the Complete Metagenome of Environmental Samples & Helps Generate Accurate Reference Genomes for Microbial Identification
8.5 Metatranscriptomics
8.5.1 Metatranscriptomics Helps in the Understanding of the Active Functional Profile of A Microbial Community
9 Metagenomic Sequencing Market, By Application (Page No. – 56)
9.1 Introduction
9.2 Drug Discovery
9.2.1 Drug Discovery Accounts for the Largest Share of the Market
9.3 Ecological & Environmental Applications
9.3.1 Metagenomic Sequencing Can Help Identify Invasive and Endangered Species
9.4 Clinical Diagnostics
9.4.1 Advantages of Metagenomic Ngs Have Enabled Wide Applications in Diagnostics
9.5 Soil Microbiome Applications
9.5.1 North America Shows High Demand for Metagenomic Sequencing in Soil Microbiome Applications
9.6 Industrial Applications
9.6.1 Energy
9.6.1.1 Declining Fossil Fuel Reserves and Growing Energy Needs Will Drive Demand Growth in This Application Segment
9.6.2 Bioremediation
9.6.2.1 Need to Monitor Pollutant Impact and Contamination Will Provide Opportunities for Metagenomic Sequencing in Bioremediation
9.6.3 Other Industrial Applications
9.7 Veterinary Applications
9.7.1 Demand for Rapid and Accurate Pathogen Diagnosis is Supporting Demand for Sequencing
9.8 Other Applications
10 Metagenomic Sequencing Market, By Region (Page No. – 67)
10.1 Introduction
10.2 North America
10.2.1 US
10.2.1.1 Well-Established Infrastructure and Funding Sources Required for Overall Ngs Based Small- and Medium-Sized Research Studies and Projects Make the US the Largest Market in North America
10.2.2 Canada
10.2.2.1 Growing Focus of Ngs Players on Expanding their Presence in Canada and Increasing Government Initiatives to Support Genomics Research and Workshops to Support Growth in This Market
10.3 Europe
10.3.1 Germany
10.3.1.1 Germany has Witnessed A Significant Increase in Investments in Next-Generation Technologies, Making It the Largest Market in Europe
10.3.2 UK
10.3.2.1 The UK is One of the Leaders in Biotechnology in the European Region Owing to the Presence of A Large Number of Ngs Players in the Country
10.3.3 France
10.3.3.1 Government Initiatives to Support Genomics Research are Primarily Driving the Growth of the Metagenomic Sequencing Market in France
10.3.4 Rest of Europe
10.4 Asia Pacific
10.4.1 China
10.4.1.1 Several Ngs Players are Focusing on Strengthening their Presence and Offerings in China
10.4.2 Japan
10.4.2.1 Rising Use of Metagenomic Sequencing for Various Application to Drive Market Growth in Japan
10.4.3 India
10.4.3.1 Decreasing Cost of Sequencing to Drive Market Growth in India
10.4.4 Rest of Asia Pacific
10.5 Rest of the World
10.5.1 Latin America
10.5.2 Middle East
10.5.3 Africa
11 Competitive Landscape (Page No. – 95)
11.1 Introduction
11.2 Market Ranking Analysis
11.3 Competitive Scenario
11.3.1 Acquisitions
11.3.2 Agreements
11.4 Competitive Leadership Mapping
11.4.1 Competitive Leadership Mapping: Major Market Players (2018)
11.4.2 Visionary Leaders
11.4.3 Innovators
11.4.4 Dynamic Players
11.4.5 Emerging Companies
12 Company Profiles (Page No. – 100)
12.1 BGI Group
12.2 DNAstar, Inc.
12.3 Eurofins Scientific
12.4 GENEWIZ
12.5 Illumina, Inc.
12.6 Integragen SA
12.7 Macrogen, Inc.
12.8 Microsynth AG
12.9 Novogene Co., Ltd.
12.10 NuGEN Technologies, Inc. (A Wholly Owned Subsidiary of Tecan Trading AG)
12.11 Oxford Nanopore Technologies, Ltd.
12.12 Perkinelmer, Inc.
12.13 QIAGEN N.V.
12.14 Thermo Fisher Scientific, Inc.
12.15 Zymo Research Corporation
13 Appendix (Page No. – 142)
13.1 Discussion Guide
13.2 Knowledge Store: Marketsandmarkets’ Subscription Portal
13.3 Available Customizations
13.4 Related Reports
13.5 Author Details